Douglas J. DiGirolamo

2.4k total citations · 1 hit paper
18 papers, 1.9k citations indexed

About

Douglas J. DiGirolamo is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Douglas J. DiGirolamo has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Oncology. Recurrent topics in Douglas J. DiGirolamo's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Bone Metabolism and Diseases (7 papers) and Muscle Physiology and Disorders (5 papers). Douglas J. DiGirolamo is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Bone Metabolism and Diseases (7 papers) and Muscle Physiology and Disorders (5 papers). Douglas J. DiGirolamo collaborates with scholars based in United States, Australia and Germany. Douglas J. DiGirolamo's co-authors include Thomas L. Clemens, Keertik Fulzele, Ryan C. Riddle, Xuemei Cao, Marie–Claude Faugere, Karyn A. Esser, Mehboob A. Hussain, Chao Wan, Susan Aja and Dongquan Chen and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Douglas J. DiGirolamo

18 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition

2010 603 citations Keertik Fulzele, Ryan C. Riddle et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. DiGirolamo United States	17	1.0k	538	479	459	358	18	1.9k
R. Clay Bunn United States	28	1.2k 1.2×	541 1.0×	287 0.6×	578 1.3×	434 1.2×	46	2.6k
Keertik Fulzele United States	17	997 1.0×	299 0.6×	277 0.6×	443 1.0×	524 1.5×	37	1.9k
Victoria DeMambro United States	23	825 0.8×	285 0.5×	396 0.8×	307 0.7×	274 0.8×	46	1.6k
Julie Lacombe United States	21	800 0.8×	269 0.5×	217 0.5×	230 0.5×	305 0.9×	39	2.1k
Jude E. Onyia United States	22	1.4k 1.3×	157 0.3×	418 0.9×	350 0.8×	774 2.2×	32	2.4k
Andrei S. Chagin Sweden	27	911 0.9×	291 0.5×	158 0.3×	168 0.4×	260 0.7×	60	2.1k
Francesca Gori United States	29	2.1k 2.1×	677 1.3×	448 0.9×	915 2.0×	1.1k 3.0×	68	3.9k
Sutada Lotinun United States	32	2.2k 2.1×	233 0.4×	633 1.3×	849 1.8×	993 2.8×	70	3.8k
Satoru Kamekura Japan	17	1.8k 1.8×	159 0.3×	304 0.6×	581 1.3×	590 1.6×	25	3.2k
Guisheng Zhao United States	16	1.0k 1.0×	501 0.9×	135 0.3×	238 0.5×	372 1.0×	29	1.7k

Countries citing papers authored by Douglas J. DiGirolamo

Since Specialization

Citations

This map shows the geographic impact of Douglas J. DiGirolamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. DiGirolamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. DiGirolamo more than expected).

Fields of papers citing papers by Douglas J. DiGirolamo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. DiGirolamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. DiGirolamo. The network helps show where Douglas J. DiGirolamo may publish in the future.

Co-authorship network of co-authors of Douglas J. DiGirolamo

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. DiGirolamo. A scholar is included among the top collaborators of Douglas J. DiGirolamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. DiGirolamo. Douglas J. DiGirolamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Spector, Alexander A., et al.. (2017). Biophysical Stimulation for Engineering Functional Skeletal Muscle. Tissue Engineering Part B Reviews. 23(4). 362–372. 33 indexed citations

Goh, Brian C., Vandana Singhal, Angelica J. Herrera, et al.. (2017). Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass. Journal of Biological Chemistry. 292(33). 13809–13822. 51 indexed citations

DiGirolamo, Douglas J., Vandana Singhal, Xiaoli Chang, Se‐Jin Lee, & Emily L. Germain‐Lee. (2015). Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta. Bone Research. 3(1). 14042–14042. 45 indexed citations

Girgis, Christian M., Nancy Mokbel, & Douglas J. DiGirolamo. (2014). Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone?. Current Osteoporosis Reports. 12(2). 142–153. 80 indexed citations

Kim, Jung‐Hyun, Vandana Singhal, Shyam Biswal, Rajesh K. Thimmulappa, & Douglas J. DiGirolamo. (2014). Nrf2 is required for normal postnatal bone acquisition in mice. Bone Research. 2(1). 14033–14033. 47 indexed citations

Riddle, Ryan C., Julie L. Frey, Ryan E. Tomlinson, et al.. (2014). Tsc2 Is a Molecular Checkpoint Controlling Osteoblast Development and Glucose Homeostasis. Molecular and Cellular Biology. 34(10). 1850–1862. 50 indexed citations

Singhal, Vandana, Brian C. Goh, Mary Bouxsein, Marie–Claude Faugere, & Douglas J. DiGirolamo. (2013). Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes. Bone Research. 1(1). 85–97. 16 indexed citations

Huri, Pınar Yılgör, Colin A. Cook, Daphne L. Hutton, et al.. (2013). Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells. Biochemical and Biophysical Research Communications. 438(1). 180–185. 49 indexed citations

DiGirolamo, Douglas J., Douglas P. Kiel, & Karyn A. Esser. (2013). Bone and Skeletal Muscle: Neighbors With Close Ties. Journal of Bone and Mineral Research. 28(7). 1509–1518. 151 indexed citations

10.

DiGirolamo, Douglas J., Thomas L. Clemens, & Stavroula Kousteni. (2012). The skeleton as an endocrine organ. Nature Reviews Rheumatology. 8(11). 674–683. 130 indexed citations

11.

Zhang, Yue, Douglas J. DiGirolamo, Jing Jiang, et al.. (2010). Deletion of IGF-I Receptor (IGF-IR) in Primary Osteoblasts Reduces GH-Induced STAT5 Signaling. Molecular Endocrinology. 24(3). 644–656. 29 indexed citations

12.

DiGirolamo, Douglas J., Yong Fan, Ryan C. Riddle, et al.. (2010). Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. Journal of Clinical Investigation. 120(11). 4007–4020. 169 indexed citations

13.

Fulzele, Keertik, Ryan C. Riddle, Douglas J. DiGirolamo, et al.. (2010). Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition. Cell. 142(2). 309–319. 603 indexed citations breakdown →

14.

Fan, Yong, Ram K. Menon, Pinchas Cohen, et al.. (2009). Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism. Journal of Biological Chemistry. 284(30). 19937–19944. 206 indexed citations

15.

DiGirolamo, Douglas J., Aditi Mukherjee, Keertik Fulzele, et al.. (2007). Mode of Growth Hormone Action in Osteoblasts. Journal of Biological Chemistry. 282(43). 31666–31674. 80 indexed citations

16.

Fulzele, Keertik, Douglas J. DiGirolamo, Zhongyu Liu, et al.. (2007). Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action. Journal of Biological Chemistry. 282(35). 25649–25658. 118 indexed citations

17.

Richert, Monica M., Pushkar Phadke, Gail L. Matters, et al.. (2005). Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment. Breast Cancer Research. 7(5). R819–27. 24 indexed citations

18.

Mastro, Andrea M., Carol V. Gay, Danny R. Welch, et al.. (2003). Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation. Journal of Cellular Biochemistry. 91(2). 265–276. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact